Coupling chromosome conformation capture to molecular enrichment for promoter-containing DNA fragments enables the systematic mapping of interactions between individual distal regulatory sequences and their target genes. In this Minireview, we describe recent progress in the application of this technique and related complementary approaches to gain insight into the lineage-and celltype-specific dynamics of interactions between regulators and gene promoters.
Distal regulatory elements, such as enhancers, play a central role in controlling expression in mammalian genomes. Enhancer sequences act as substrates for binding of tissue-specific transcription factors and drive transcription through physical interaction with gene promoters (Spitz and Furlong, 2012) . Recent chromatin profiling studies reveal the exceptional cell type and temporal specificity of enhancer activity, which exceeds that of other classes of gene regulatory sequences (Ernst and Kellis, 2010; Nord et al., 2013) . This stunning specificity, alongside advances in sequencing technologies and the increasingly recognized importance of non-coding sequences in human development and disease, has driven large-scale efforts to annotate regulatory elements and gene transcription in the human genome under a wide variety of conditions. The International Human Epigenome Consortium (IHEC) (Bae, 2013) connects many of these projects, with the goal of characterizing 1,000 epigenomes from different human cell types at diverse developmental stages and disease states.
New studies published in this issue of Cell and in Cell Reports and described in greater detail throughout the following sections of this Minireview build upon IHEC efforts to explore the role of cell-type-specific regulation and begin to address several important challenges in the field (Schmitt et al., 2016; Javierre et al., 2016; Breeze et al., 2016; Pellacani et al., 2016) . In brief, Pellacani et al. (2016) tackle the question of cell type specificity of enhancers across the individual cell types that make up heterogeneous tissues. The authors use chromatin profiling methods to identify regulatory elements active in the distinct cell populations that comprise mammary tissue. While chromatin profiling is powerful for identifying predicted enhancer sequences, it is limited in its ability to elucidate the gene target(s) of the predicted enhancers. To address this challenge, Javierre et al. (2016) (Schmitt et al., 2016; Javierre et al., 2016; Pellacani et al., 2016) along with a computational algorithm capable of integrating epigenomic findings described in Breeze et al. (2016) provide handy tools for addressing the gap between disease-associated non-coding variants and their regulatory gene targets. Using these complementary techniques to explore the regulatory landscape in human tissues and isolated primary cell populations, these studies report insights and resources that will be instrumental in linking variants with causal mechanisms of disease.
Insights into Cell-Type-Specific Regulation Histone ChIP-seq has now become a standard method to identify regulatory regions genome-wide (Park, 2009). ChIPseq combines chromatin immunoprecipitation of modified histones with high-throughput sequencing to identify active enhancers and other regulatory features. While the underlying DNA sequence does not vary between cell types, histone modifications mark regions that are active or repressed in vivo in a tissue-specific manner. When paired with technologies for capturing specific cell types, ChIP-seq can be used to identify differential regulation in cell populations derived from heterogeneous tissue. An elegant example of this approach is provided by Pellacani et al. (2016) , who generate histone ChIP-seq, DNA methylation, and gene expression data to identify cell-type-specific regulatory elements in primary human mammary tissue. Consistent with previous findings (Gascard et al., 2015) , their results show widespread differences among the different cell types isolated from this heterogeneous tissue and relative to previous results from immortalized mammary cell lines. The biological relevance of these observations is reinforced by the findings that differential enhancer utilization in mammary cell types is consistent with cell-specific gene expression and that cell-type-specific enhancers are enriched for unique
